2024 ASCO Highlights: Focus on HER2+ Breast Cancer (Part 1)
Release Date:
Drs. Claudine Isaacs and Filipa Lynce discuss highlights of the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting, with a focus on HER2+ breast cancer, including late-breaking abstracts such as DESTINY‑Breast06 and others.
2024 ASCO Highlights: Focus on HER2+ Breast Cancer (Part 1)